Zantac: CVS latest to suspend heartburn drug over cancer fears

CVS pharmacies become the latest to withdraw Zantac, a drug being investigated for cancer links.

About the Author

has written 39590 stories on this site.

Copyright © 2010 Business and Corporate News.